LAUSR

&NA; In Northern Ireland there are concerns about candidaemia, with rates higher than those reported in England and Wales. Our aim was to explore the epidemiology of candidaemia during a 10 year period and the clinical management upon suspicion of cases during a one year enhanced investigation in Northern Ireland. Candidaemia reports to the Public Health Agency were validated during 2002–2011 and used to examine incidence and antifungal sensitivity trends (during 2007–2011). A clinical proforma was used to collate information for all patients with candidaemia in 2011. The majority (96%) of isolates were captured through voluntary laboratory reporting. There was a year‐on‐year increase in candidaemia from 2002–2011, from 80 to 131 episodes (incidence rate ratio 1.09 95% CI 1.05–1.13). Rates were highest in males under 1 year and over 75 years. 83/98 (85%) of case notes were available from candidaemia patients during 2011. The most prevalent risk factors were patients on total parenteral nutrition (26 people, 31.3%), surgery in the two months prior to the candidaemia (25 people, 30.1%), significant steroid use in the previous 3 months (24 people, 28.9%) and active neoplastic disease (23 people, 27.7%), This study confirmed an increase in candidaemia rates over time, with the observed incidence in 2011 higher than England and Wales. We identified areas for improvement around the clinical management of candidaemia. We recommend raising the awareness of guidelines for fundoscopy, echocardiography and central venous catheter removal.